[HTML][HTML] The immune response to SARS-CoV-2 in people with HIV

MA Höft, WA Burgers, C Riou - Cellular & Molecular Immunology, 2024 - nature.com
This review examines the intersection of the HIV and SARS-CoV-2 pandemics. People with
HIV (PWH) are a heterogeneous group that differ in their degree of immune suppression …

[HTML][HTML] Immunologic interplay between HIV/AIDS and COVID-19: adding fuel to the flames?

M Augello, V Bono, R Rovito, C Tincati… - Current HIV/AIDS …, 2023 - Springer
Abstract Purpose of Review HIV/AIDS and COVID-19 have been the major pandemics
overwhelming our times. Given the enduring immune disfunction featuring people living with …

[HTML][HTML] Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4+ and CD8+ T cell-SARS-CoV-2 response: comparison with …

A Aiello, A Coppola, V Vanini, L Petrone… - International Journal of …, 2022 - Elsevier
Objectives: In this study, we aimed to characterize the SARS-CoV-2-specific T cell response
detected by the QuantiFERON SARS-CoV-2 research use only assay in terms of accuracy …

[HTML][HTML] Hybrid immunity expands the functional humoral footprint of both mRNA and vector-based SARS-CoV-2 vaccines

P Kaplonek, Y Deng, JSL Lee, HJ Zar, D Zavadska… - Cell Reports …, 2023 - cell.com
Despite the successes of current coronavirus disease 2019 (COVID-19) vaccines, waning
immunity, the emergence of variants of concern, and breakthrough infections among …

[HTML][HTML] SARS-CoV-2 T cell immunity responses following natural infection and vaccination

VC Pitiriga, M Papamentzelopoulou… - Vaccines, 2023 - mdpi.com
(1) Background: SARS-CoV-2 T cell immunity is rapidly activated following SARS-CoV-2
infection and vaccination and is crucial for controlling infection progression and severity. The …

[HTML][HTML] A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 …

E Sabetta, M Noviello, C Sciorati, M Viganò… - Frontiers in …, 2023 - frontiersin.org
Introduction SARS-CoV-2 mRNA vaccinations elicit both virus-specific humoral and T-cell
responses, but a complex interplay of different influencing factors, such as natural immunity …

[HTML][HTML] Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination

D Lo Tartaro, A Paolini, M Mattioli, J Swatler… - Frontiers in …, 2023 - frontiersin.org
The formation of a robust long-term antigen (Ag)-specific memory, both humoral and cell-
mediated, is created following severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different …

A Aiello, A Coppola, S Ruggieri, C Farroni… - Journal of Neurology …, 2023 - jnnp.bmj.com
Background The decline of humoral response to COVID-19 vaccine led to authorise a
booster dose. Here, we characterised the kinetics of B-cell and T-cell immune responses in …

[HTML][HTML] Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose

M Belik, O Liedes, S Vara, A Haveri, S Pöysti… - Frontiers in …, 2023 - frontiersin.org
Introduction The prime-boost COVID-19 mRNA vaccination strategy has proven to be
effective against severe COVID-19 disease and death. However, concerns have been raised …

[HTML][HTML] Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS …

M Augello, V Bono, R Rovito, C Tincati, AA Monforte… - Aids, 2023 - journals.lww.com
Objective: Immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) mRNA vaccines in people with HIV (PWH) with a history of late presentation (LP) …